The Prostate

Cover image for Vol. 75 Issue 15

November 1, 2015

Volume 75, Issue 15

Pages 1677–1820

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3) (pages 1677–1681)

      Sarah C. Markt, Irene M. Shui, Robert H. Unger, Yuksel Urun, Christine D. Berg, Amanda Black, Paul Brennan, H. Bas Bueno-de-Mesquita, Susan M. Gapstur, Edward Giovannucci, Christopher Haiman, Brian Henderson, Robert N. Hoover, David J. Hunter, Timothy J. Key, Kay-Tee Khaw, Federico Canzian, Nerea Larranga, Loic Le Marchand, Jing Ma, Alessio Naccarati, Afshan Siddiq, Meir J. Stampfer, Par Stattin, Victoria L. Stevens, Daniel O. Stram, Anne Tjønneland, Ruth C. Travis, Dimitrios Trichopoulos, Regina G. Ziegler, Sara Lindstrom, Peter Kraft, Lorelei A. Mucci, Toni K. Choueiri and Kathryn M. Wilson

      Article first published online: 13 AUG 2015 | DOI: 10.1002/pros.23035

    2. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy (pages 1682–1693)

      Yngve Nordby, Sigve Andersen, Elin Richardsen, Nora Ness, Samer Al-Saad, Christian Melbø-Jørgensen, Hiten RH Patel, Tom Dønnem, Lill-Tove Busund and Roy M Bremnes

      Article first published online: 13 AUG 2015 | DOI: 10.1002/pros.23048

    3. Metformin effects on biochemical recurrence and metabolic signaling in the prostate (pages 1694–1703)

      Brian Winters, Stephen Plymate, Steven B. Zeliadt, Sarah Holt, Xiaotun Zhang, Elaine Hu, Daniel W. Lin, Colm Morrissey, Bryan Wooldridge, John L. Gore, Michael P. Porter and Jonathan L. Wright

      Article first published online: 22 JUL 2015 | DOI: 10.1002/pros.23049

    4. Relationship between serum response factor and androgen receptor in prostate cancer (pages 1704–1717)

      Maria Prencipe, Amanda O'Neill, Gillian O'Hurley, Lan K. Nguyen, Aurelie Fabre, Anders Bjartell, William M. Gallagher, Colm Morrissey, Elaine W. Kay and R. William Watson

      Article first published online: 7 AUG 2015 | DOI: 10.1002/pros.23051

    5. Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer (pages 1718–1725)

      Kathryn Hughes Barry, Lee E. Moore, Linda M. Liao, Wen-Yi Huang, Gabriella Andreotti, Matthew Poulin and Sonja I. Berndt

      Article first published online: 7 AUG 2015 | DOI: 10.1002/pros.23053

    6. Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant prostate cancer (pages 1747–1759)

      Hongzoo Park, Yunlim Kim, Jee-Won Sul, In Gab Jeong, Hye-Jin Yi, Jae Beom Ahn, Jong Soon Kang, Jieun Yun, Jung Jin Hwang and Choung-Soo Kim

      Article first published online: 7 AUG 2015 | DOI: 10.1002/pros.23057

    7. Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [11C]acetate PET as a prognostic marker (pages 1760–1767)

      Asha Leisser, Konstatin Pruscha, Philipp Ubl, Wolfgang Wadsak, Marius Mayerhöfer, Markus Mitterhauser, Marcus Hacker, Gero Kramer, Shahrokh Shariat, Georgios Karanikas, Markus Hartenbach and Alexander R. Haug

      Article first published online: 18 AUG 2015 | DOI: 10.1002/pros.23061

    8. Tumor volume in insignificant prostate cancer: Increasing the threshold is a safe approach to reduce over-treatment (pages 1768–1773)

      Francis Ting, Pim J. van Leeuwen, Warick Delprado, Anne-Maree Haynes, Phillip Brenner and Phillip D. Stricker

      Article first published online: 18 AUG 2015 | DOI: 10.1002/pros.23062

    9. Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat (pages 1774–1782)

      Felix Holmström, Shogo Shimizu, Takahiro Shimizu, Youichirou Higashi, Darryl T. Martin, Masashi Honda and Motoaki Saito

      Article first published online: 19 AUG 2015 | DOI: 10.1002/pros.23063

    10. Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer (pages 1783–1789)

      Seyfettin Ciftci, Hasan Yilmaz, Esra Ciftci, Emrah Simsek, Murat Ustuner, Ufuk Yavuz, Bahar Muezzinoglu and Ozdal Dillioglugil

      Article first published online: 19 AUG 2015 | DOI: 10.1002/pros.23067

    11. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence (pages 1790–1801)

      Aaron M. Horning, Julius A. Awe, Chiou-Miin Wang, Joseph Liu, Zhao Lai, Vickie Yao Wang, Rohit R. Jadhav, Anna D. Louie, Chun-Lin Lin, Tad Kroczak, Yidong Chen, Victor X. Jin, Sherry L. Abboud-Werner, Robin J. Leach, Javior Hernandez, Ian M. Thompson, Jeff Saranchuk, Darrel Drachenberg, Chun-Liang Chen, Sabine Mai and Tim Hui-Ming Huang

      Article first published online: 1 SEP 2015 | DOI: 10.1002/pros.23052

    12. Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer (pages 1814–1820)

      Benjamin L. Maughan, Xian C. Xhou, Daniel L. Suzman, Rosa Nadal, Sunakshi Bassi, Michael T. Schweizer and Emmanuel S. Antonarakis

      Article first published online: 26 AUG 2015 | DOI: 10.1002/pros.23064